Modified fasting therapy

1 paper3 findings

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

Labs are independent when their papers share no last author and no institution.

Against: findings that point the other way from most findings on the same outcome.

On aging: the drug’s trials ARN judged to be about aging, of every trial that tests it for any use.

No results posted: trials that ended more than a year ago with no results on ClinicalTrials.gov and no paper in ARN’s record.

Company ties: findings with an author at a company, or from a paper whose competing-interests statement declares ties to one.

1 lab in 1 country

Funders: Basic and Applied Basic Research Foundation of Guangdong Province and 1 more

Human trial1

Outcomes

Blood glucose

downin humans1

1 study

Modified fasting therapy decreases blood glucose in humans (p < 0.05).
“accompanied by marked improvements in blood glucose and lipid profiles (p < 0.05).”
Human trial550 kcal/day7-dayn = 35
Effects of modified fasting therapy on tongue coating and gut microbiome in overweight and obese adults: a controlled clinical trial
Frontiers in nutrition23 Jan 2026

Latest

1 in 12 months

Frontiers in Nutrition9 Feb

Effects of modified fasting therapy on tongue coating and gut microbiome in overweight and obese adults: a controlled clinical trial

Non-randomised trial in 48 peopleOverweight

Paper

Modified fasting therapy

Outcomes

Latest

Effects of modified fasting therapy on tongue coating and gut microbiome in overweight and obese adults: a controlled clinical trial

Related